Drug
KISS1 protein, human clinical trials
Also written Kisspeptin-10.
- studies test it
- 15
- open now
- 3
- in phase 3
- 2
- first study started
- 2009
Keep track of what changes. Save the KISS1 protein, human studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
15 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2019 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 15
Stephanie B. Seminara, MD (8) · Massachusetts General Hospital (5) · Quaid-e-Azam University (1) · Ghulam Nabi (1)
Often tested with
Tested in the same studies.
Gonadotropin-Releasing Hormone (6) · Naloxone (1) · Leuprolide (1)
Studies
Open first, then newest update. How each study uses KISS1 protein, human is read from its arms, and is right about nine times in ten.
Testing it · 15
- Kisspeptin Administration Subcutaneously to Patients With IHHRecruitingPhase 2Stephanie B. Seminara, MDNCT05896293Written as kisspeptin 112-121
- Kisspeptin to Quantify GnRH Neuronal Function in Health and DiseaseRecruitingPhase 1Stephanie B. Seminara, MDNCT07224490Written as Kisspeptin 112-121
- Kisspeptin Administration Subcutaneously to Patients With Hypothalamic AmenorrheaRecruitingPhase 2Stephanie B. Seminara, MDNCT07224438Written as kisspeptin 112-121
- Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic HypogonadismCompletedPhase 2Stephanie B. Seminara, MDNCT04648969Written as kisspeptin 112-121
- Recall by Genotype: Neuropeptide StimulationTerminatedPhase 1Stephanie B. Seminara, MDNCT05901467Written as kisspeptin 112-121
- Dampening the Reproductive Axis With Continuous KisspeptinCompletedPhase 1Stephanie B. Seminara, MDNCT05971849Written as kisspeptin 112-121
- Kisspeptin Administration Subcutaneously to Patients With Reproductive DisordersCompletedPhase 1Stephanie B. Seminara, MDNCT05633966Written as Kisspeptin 112-121
- Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic ClampWithdrawnPhase 1Massachusetts General HospitalNCT05456854Written as Kisspeptin-10
- Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal ToleranceWithdrawnPhase 1Stephanie B. Seminara, MDNCT04532801Written as Kisspeptin-10
- Neuropeptides in Human ReproductionCompletedPhase 1Massachusetts General HospitalNCT01952782Written as Kisspeptin 112-121
- Kisspeptin Administration in the AdultCompletedPhase 1Massachusetts General HospitalNCT00914823Written as kisspeptin 112-121
- Kisspeptin in the Evaluation of Delayed PubertyCompletedPhase 1Massachusetts General HospitalNCT01438034Written as kisspeptin 112-121
- Elucidating Kisspeptin Physiology by Blocking Kisspeptin SignalingCompletedPhase 1Massachusetts General HospitalNCT01438073Written as kisspeptin 112-121
- KP-10 and Insulin Secretion in MenCompletedPhase 3Quaid-e-Azam UniversityNCT03771326Written as Kisspeptin-10
- Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.CompletedPhase 3Ghulam NabiNCT03286517Written as Kisspeptin-10 (metastin 45-54, Calbiochem, Darmstadt, Germany)